tradingkey.logo

Haleon PLC

HLN
View Detailed Chart

9.465USD

-0.175-1.82%
Market hours ETQuotes delayed by 15 min
85.69BMarket Cap
59.42P/E TTM

Haleon PLC

9.465

-0.175-1.82%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.82%

5 Days

-2.92%

1 Month

-8.73%

6 Months

-1.10%

Year to Date

-0.79%

1 Year

+4.01%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 5 analysts
BUY
Current Rating
11.228
Target Price
16.47%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

172
Total
5
Median
8
Average
Company name
Ratings
Analysts
Haleon PLC
HLN
5
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Amgen Inc
AMGN
33
Alnylam Pharmaceuticals Inc
ALNY
33
Gilead Sciences Inc
GILD
30
1
2
3
...
35

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(10)
Neutral(3)
Buy(0)
Indicators
Sell(4)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.050
Neutral
RSI(14)
35.559
Neutral
STOCH(KDJ)(9,3,3)
45.026
Sell
ATR(14)
0.149
Low Volatility
CCI(14)
-39.091
Neutral
Williams %R
73.585
Sell
TRIX(12,20)
-0.340
Sell
StochRSI(14)
8.393
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
9.776
Sell
MA10
9.700
Sell
MA20
9.857
Sell
MA50
10.455
Sell
MA100
10.357
Sell
MA200
10.030
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
Ticker SymbolHLN
CompanyHaleon PLC
CEOMr. Brian Mcnamara
Websitehttps://www.haleon.com/
KeyAI